Henrik Falconer

Head of GYN Oncology

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Henrik Falconer is the Head of GYN Oncology at Karolinska Universitetssjukhuset in Sweden. His research focuses on various aspects of gynecologic oncology, particularly in cervical cancer, ovarian cancer, and surgical techniques. Recently published articles include studies on oncological outcomes after radical hysterectomy and the role of pelvic lymph-node dissections in cancer surgeries. He is also involved in investigating innovative strategies for patient management in advanced stages of gynecologic cancer.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Collaborators (6)

Maaike van der Aa

Netherlands Comprehensive Cancer Organisation

NETHERLANDS

View details

Jan Persson

Professor

Lund University

SWEDEN

View details

Mihaela Asp

Lund University

SWEDEN

View details

Jiri Jarkovsky

Masaryk University

CZECH REPUBLIC

View details

Katrine Fuglsang

Aarhus University

DENMARK

View details

Pernille Tine Jensen

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Henrik Falconer

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Effect of intraperitoneal ropivacaine during and after cytoreductive surgery on time-interval to adjuvant chemotherapy in advanced ovarian cancer: a randomised, double-blind phase III trial

Response to Letter Re: Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2- a multinational population-based cohort study

Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 – A multinational population-based cohort study

Trachelectomy and Cerclage Placement as Fertility-Sparing Surgery for Cervical Cancer—An Expert Survey

Pelvic lymph-node dissections in bladder and prostate cancer surgery and the risk of postoperative venous thromboembolism

Extensive cytoreductive surgery in stage IV ovarian cancer may not be a justified treatment strategy

Oncologic outcomes after Total Mesometrial Resection (TMMR) or treatment according to current international guidelines in FIGO (2009) stages IB1-IIB cervical cancer: an observational cohort study

A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases

Robot-assisted laparoscopic surgery in gynecologic oncology

The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer

Collaborators (6)

Maaike van der Aa

Jan Persson

Mihaela Asp

Jiri Jarkovsky

Katrine Fuglsang

Pernille Tine Jensen

Make your next move.